Диссертация (1140697), страница 17
Текст из файла (страница 17)
Williams (etal.) // J. Nucl. Med. – 2009. – Vol. 50. – P. 563–568.87.Imaging of macular diseases with optical coherence tomography / C.A.Puliafito, M.R. Hee, CP. Lin (et al.) // Ophthalmology. – 1995. – Vol. 102, № 2. –P. 217-29.88.Imaging the vulnerable plaque / D. Vancraeynest, A. Pasquet, V.Roelants (et al.) // J. Am. Coll. Cardiol. – 2011. – Vol.
57, № 20. – P. 1961-79.89.In vivo 18Ffluorodeoxyglucose positron emission tomography imagingprovides a non-invasive measure of carotid plaque inflammation in patients / A.Tawakol, R. Migrino, G. Bashian (et al.) // J. Am. Coll. Cardiol. – 2006. – Vol. 48. –P. 1818-1824.90.In vivo characterization of coronary atherosclerotic plaque by use ofoptical coherence tomography / I.K. Jang, G.J. Tearney, B.
MacNeill (et al.) //Circulation. – 2005. – Vol. 111, № 12. – P. 1551-5.91.In vivo comparison of optical coherence tomography and angioscopyfor the evaluation of coronary plaque characteristics / M. Tanako, I. Jang, S. Inami(et al.) // J. Am. Coll. Cardiol. – 2008. – Vol. 101. – P. 471-476.92.In vivo critical fibrous cap thickness for rupture-prone coronary plaquesassessed by optical coherence tomography / T. Yonetsu, T. Kakuta, T. Lee (et al.) //Eur. Heart J. – 2011. – Vol.
32, № 10. – P. 1251-9.93.In vivo diagnosis of plaque erosion and calcified nodule in patients withacute coronary syndrome by intravascular optical coherence tomography / H. Jia, F.120Abtahian, A.D. Aguirre (et al.) // J. Am. Coll. Cardiol.
– 2013. – Vol. 62, № 19. – P.1748-58.94.Index matching to improve optical coherence tomography imagingthrough blood / M. Brezinski, K. Saunders, C. Jesser (et al.) // Circulation. – 2001. –Vol. 103, № 15. – P. 1999-2003.95.Intra-coronary thrombus evolution during acute coronary syndrome:regression assessment by serial optical coherence tomography analyses / N.Amabile, S. Hammas, S. Fradi (et al.) // Eur. Heart J. Cardiovasc. Imaging. – 2015.– Vol. 16, № 4. – P. 433-40.96.Intravascularultrasoundguidanceofpercutaneouscoronaryintervention in ostial chronic total occlusions: a description of the technique andprocedural results / N. Ryan, N. Gonzalo, P.
Dingli (et al.) // Int. J. Cardiovasc.Imaging. – 2017. – Vol. 33, № 6. – P. 807-813.97.Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definitionof Myocardial Infarction, Third universal definition of myocardial infarction / K.Thygesen, J.S. Alpert, A.S. Jaffe (et al.) // Circulation. – 2012. – 126, № 16. – P.2020-35.98.Keeley, C. Primary angioplasty versus intravenous thrombolytictherapy for acute myocardial infarction: a quantitative review of randomised trials /C. Keeley, J.A.
Boura, C.L. Grines // Lancet. – 2003. – Vol. 361. – P. 13–20.99.Lessons from sudden coronary death: a comprehensive morphologicalclassification scheme for atherosclerotic lesions / R. Virmani, F.D. Kolodgie, A.P.Burke (et al.) // Arterioscler. Thromb. Vasc. Biol. – 2000. – Vol. 20. – P. 1262-75.100. Lipid Assessment Trial Italian Network (LATIN) Investigators.Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction /R. Latini, A.P. Maggioni, G.
Peri (et al.) // Circulation. – 2004. – Vol. 110, № 16. –P. 2349-54.101. Longitudinal distribution of plaque burden and necrotic core richplaques in nonculprit lesions of patients presenting with acute coronary syndromes /121J. Wykrzykowska, G. Mintz, H. Garcia-Garcia (et al.) // J. Am. Coll. Cardiol.Cardiovasc. Imaging. – 2012.
– Vol. 5, № 3. – P. 10-18.102. Long-term benefit of primary angioplasty as compared withthrombolytic therapy for acute myocardial infarction / F. Zijlstra, J.C. Hoorntje,M.J. de Boer (et al.) // N. Engl. J. Med. – 1999. – Vol. 341. – P. 1413–9.103. Manual Thrombus Aspiration Is Not Associated With ReducedMortality in Patients Treated With Primary Percutaneous Coronary Intervention: AnObservational Study of 10,929 Patients With ST-Segment Elevation MyocardialInfarction From the London Heart Attack Group / D.A.
Jones, K.S. Rathod,S.Gallagher (et al.) // JACC Cardiovasc. Interv. – 2015. – Vol. 8, № 4. – P. 575-84.104. Markers of myocardial damage and inflammation in relation to longterm mortality in unstable coronary disease. FRISC substudy group. Fragmin duringInstability in Coronary artery disease / B.
Lindahl, H. Toss, A. Siegbahn (et al.) // N.Engl. J. Med. - 2000. - Vol. 343. - P. 1139-1147.105. Mechanical and structural characteristics of vulnerable plaques:Analysis by coronary angioscopy and intravascular ultrasound / M. Takano, K.Mizuno, K. Okamatsu (et al.) // J. Am. Coll. Cardiol. – 2001. – Vol. 38. – P. 99-104.106.
Mechanisms of atherothrombosis and vascular response to primarypercutaneous coronary intervention in women versus men with acute myocardialinfarction: results of the OCTAVIA Study / G. Guagliumi, D. Capodanno, F. Saia(et al.) // J. Am. Coll. Cardiol. Intv. – 2014. – № 7. – P. 958–68.107. Mintz, G.S. Intravascular imaging in coronary artery disease / G.S.Mintz, G. Guagliumi // Lancet.
– 2017. – Vol. 390. – P. 793–809.108. Morphology of vulnerable coronary plaque: Insights from follow-up ofpatients examined by intravascular ultrasound before an acute coronary syndrome /M. Yamagishi, M. Terashima, K. Awano (et al.) // J. Am. Coll. Cardiol. – 2000. –Vol. 35. – P. 106–111.109.
Multi-laboratory interinstitute reproducibility study of IVOCT andIVUS assessments using published consensus document definitions / E. Gerbaud, G.122Weisz, A. Tanaka (et al.) // Eur. Heart J. Cardiovasc. Imaging. – 2016. – Vol. 17. –P. 756–64.110. Multiple coronary lesion instability in patients with acute myocardialinfarction as determined by optical coherence tomography / T. Kubo, T. Imanishi,M. Kashiwagi (et al.) // Am. J. Cardiol.
– 2010. – Vol. 105, № 3. – P. 318–22.111. Neutrophil Extracellular Traps Kill Bacteria / V. Brinkmann, U.Reichard, C. Goosmann (et al.) // Science. – 2004. - № 303 (5663). – P. 1532–1535.112. Nissen, S.E. Intravascular ultrasound: novel pathophysiological insightsand current clinical applications / S.E. Nissen, P. Yock // Circulation. – 2001. – Vol.103, № 4. – P. 604-16.113.
Noncalcified atherosclerotic lesions with vulnerable characteristicsdetected by coronary CT angiography and future coronary events / H. Yamamoto, T.Kitagawa, N. Ohashi (et al.) // J. Cardiovasc. Comput. Tomography. – 2013. – № 7.– P. 192-199.114. Norata, G.D. The long pentraxin PTX3: a modulator of theimmunoinflammatory response in atherosclerosis and cardiovascular diseases / G.D.Norata, C. Garlanda, A.L. Catapano // Trends Cardiovasc. Med.
– 2010. – Vol. 20,№ 2. – P. 35-40.115. OCT compared with IVUS in a coronary lesion assessment: the OPUSCLASS study / T. Kubo, T. Akasaka, J. Shite (et al.) // JACC Cardiovasc. Imaging.– 2013. - № 6. – P. 1095–104.116. OCT-based diagnosis and management of STEMI associated withintact fibrous cap / F. Prati, S. Uemura, G. Souteyrand (et al.) // JACC Cardiovasc.Imaging.
– 2013. – Vol. 6, № 3. – P. 283-7.117. Optical coherence tomography / D. Huang, E.A. Swanson, C.P. Lin (etal.) // Science. – 1991. – № 254 (5035). – P. 1178-81.118. Optical coherence tomography for optical biopsy. Properties anddemonstration of vascular pathology / M.E. Brezinski, G.J. Tearney, B.E. Bouma (etal.) // Circulation. – 1996. – Vol. 93, № 6. – P. 1206-13.123119. Pancoronary plaque vulnerability in patients with acute coronarysyndrome and ruptured culprit plaque: a 3-vessel optical coherence tomographystudy / R. Vergallo, X. Ren, T.
Yonetsu (et al.) // Am. Heart J. – 2014. – Vol. 167,№ 1. – P. 59-67.120. Pathology of the vulnerable plaque / R. Virmani, A.P. Burke, A. Farb,F.D. Kolodgie // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – P. C13–8.121. Pentraxin 3 as a biomarker for acute coronary syndrome: Comparisonwith biomarkers for cardiac damage / N. Kume, H.
Mitsuoka, K. Hayashida, M.Tanaka // J. Cardiol. – 2011. – Vol. 58, № 1. – P. 38-45.122. Pentraxin 3 in unstable angina and nonST-segment elevationmyocardial infarction / S. Matsui, J. Ishii, F. Kitagawa (et al.) // Atherosclerosis. –2010. – Vol. 210. – P. 220—5.123. Pentraxin 3, a non-redundant soluble pattern recognition receptorinvolved in innate immunity / A. Mantovani, C. Garlanda, B. Bottazzi (et al.) //Vaccine.
– 2003. – Vol. 21, Suppl. 2. – P. S43-7.124. Pentraxin 3: a novel biomarker for inflammatory cardiovascular disease/ K. Inoue, T. Kodama, H. Daida (et al.) // Int. J. Vasc. Med. – 2012. – 2012. – P.657025.125. Percutaneous coronary intervention of functionally nonsignificantstenosis: 5-year follow-up of the DEFER Study / N.H. Pijls, P.
van Schaardenburgh,G. Manoharan (et al.) // J. Am. Coll. Cardiol. – 2007. – Vol. 49, № 21. – P. 210511.126. Plaque erosion is a major substrate for coronary thrombosis in acutemyocardial infarction / E. Arbustini, B. Dal Bello, P. Morbini (et al.) // Heart.
–1999. – Vol. 82. – P. 269–272.127. Plaque morphologies and the clinical prognosis of acute coronarysyndrome caused by lesions with intact fibrous cap diagnosed by optical coherencetomography / T. Yonetsu, T. Lee, T. Murai (et al.) // Int. J. Cardiol. – 2016. – Vol.15. – P. 766-74.124128.
Plaque rupture and intact fibrous cap assessed by optical coherencetomography portend different outcomes in patients with acute coronary syndrome /G. Niccoli, R.A. Montone, L. Di Vito (et al.) // Eur. Heart J. – 2015. – Vol. 36. – P.1377-1384.129. Plasma 99th percentile reference limits for cardiac troponin andcreatine kinase MB mass for use with European Society of Cardiology/AmericanCollege of Cardiology consensus recommendations / F.S. Apple, H.E. Quist, P.J.Doyle (et al.) // Clin. Chem. – 2003. – Vol. 49, № 8.
– P. 1331-6.130. Plasma brain natriuretic peptide as an indicator of left ventricularsystolic function and long-term survival after acute myocardial infarction:comparison with plasma atrial natriuretic peptide and N-terminal proatrialnatriuretic peptide / T. Omland, A. Aakvaag, V.V. Bonarjee (et al.) // Circulation. –1996. – Vol. 93. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
